TABLE 3.
Probable psychiatric diagnosis based on MINI | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Medication class1 (total number of individuals prescribed) | Major depressive disorder (n= 35) | Dysthymia (n = 38) | Suicidality (n = 15) | Mania (n =41) | Panic disorder (n = 35) | Social anxiety disorder (n = 18) | ||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Anti-anxiety (n = 34) | 16 | 45.7 | 14 | 36.8 | 5 | 33.3 | 17 | 41.5 | 16 | 45.7 | 9 | 50.0 |
SSRI (n = 23) | 11 | 31.4 | 12 | 31.6 | 7 | 46.7 | 15 | 36.6 | 14 | 40.0 | 8 | 44.4 |
Mixed Neurotransmitter Reuptake Inhibitors (n = 4) | 2 | 5.7 | 3 | 7.9 | 4 | 4.2 | 2 | 4.9 | 1 | 2.9 | 1 | 5.6 |
Tricyclics (n = 3) | 1 | 2.9 | 1 | 2.6 | 0 | 0.0 | 3 | 7.3 | 3 | 8.6 | 0 | 0.0 |
Anti-psychotics (n = 7) | 3 | 8.6 | 2 | 5.3 | 1 | 6.7 | 5 | 12.2 | 4 | 11.4 | 3 | 16.7 |
Mood Stabilizers (n = 5) | 2 | 5.7 | 3 | 7.9 | 1 | 6.7 | 3 | 7.3 | 4 | 11.4 | 0 | 0.0 |
Any Medication (n = 54) | 25 | 71.4 | 25 | 65.8 | 12 | 80.0 | 29 | 70.7 | 27 | 27.9 | 15 | 83.3 |
Probable psychiatric diagnosis based on MINI | ||||||||||||
Obsessive-compulsive disorder (n = 20) | Post-traumatic stress disorder (n = 45) | Eating disorder (n = 8) | Generalized anxiety disorder (n = 39) | |||||||||
Medication Class, cont. | n | % | n | % | n | % | n | % | ||||
Anti-anxiety | 9 | 45.0 | 17 | 37.8 | 4 | 50.0 | 17 | 43.6 | ||||
SSRI | 9 | 45.0 | 9 | 20.0 | 4 | 50.0 | 14 | 35.9 | ||||
Mixed Neurotransmitter Reuptake Inhibitors | 3 | 15.0 | 1 | 2.2 | 1 | 12.5 | 3 | 7.7 | ||||
Tricyclics | 2 | 10.0 | 2 | 4.4 | 0 | 0.0 | 3 | 7.7 | ||||
Anti-psychotics | 2 | 10.0 | 4 | 8.9 | 1 | 12.5 | 3 | 7.7 | ||||
Mood stabilizers | 2 | 10.0 | 3 | 6.7 | 0 | 0.0 | 4 | 10.3 | ||||
Any medication | 15 | 75.0 | 25 | 55.6 | 6 | 75.0 | 29 | 74.7 |
Anti-anxiety: buspirone, clonazepam, diazepam, hydroxyzine, lormetazepam, midazolam, oxazepam, passedan tropfen (Austria), Zolpidem; SSRI (Selective Serotonin Reuptake Inhibitors): citalopram, escitalopram oxalate, fluoxetine, paroxetine, sertraline; Mixed Neurotransmitter Reuptake Inhibitors: buproprion; Tricyclic Antidepressants: doxepin; Anti-psychotics: olanzapine, quetiapine fumarate, trazadone Mood Stabilizers: lamotrigine, lithium carbonate.